Search for Opportunities

Showing 17-24 of 73 jobs
Show 3 jobs at PrimaNova Technologies Limited
Simcere Pharmaceutical Group Limited Banner

抗体理化分析高级科研员(南京)

Pharmaceutical
Full-time
Rest of China
Posted on 28 May 2025

Job Function

  • Research & Development

Discipline

  • Biochemistry
  • Biological Sciences
  • Biology
  • Pharmacy

Years of Experience

  • 4-6 years

Responsibilities

  1. Responsible for SEC, IEC, CE method development, validation, transfer and sample analysis of therapeutic antibodies.
  2. Hands-on scientific expertise and problem-solving skills in CE or HPLC analysis.
  3. Co-ordinate with project teams to streamline the sample testing.
  4. Performs instrumentation routine maintenance.
  5. Fully document all protocols and results in notebook and compose summary report.
  6. Write formal reports for regulatory filings and support the generation of appropriate responses to questions from regulatory authorities.
  7. Additional responsibilities may include other physicochemical test of samples.

Requirements

  1. PhD or MS 3+ years of experience in protein biochemistry, analytical chemistry, structural biology, immunobiology, pharmaceutical science or other related disciplines.
  2. Comprehensive knowledge of HPLC and capillary electrophoresis, or other protein biochemistry techniques. Experience of working with therapeutic antibodies IND/BLA filing is a plus.
  3. Ability to implement state of the art technologies to solve complex analyitical problems.
  4. Strong capabilities in experimental design and execution.
  5. Exceptional communication skills and the ability to work in a cross-functional team environment to advance CMC development projects. Fluent in English is a plus.

Additional Information

Working location: Nanjing

About the Company

Simcere Pharmaceutical Group Limited

Industry
Pharmaceutical
View All Jobs

Overview

Simcere Pharmaceutical Group Limited (2096.HK) is a pharmaceutical company driven by innovative R&D. We are committed to "For patients, for life." across the following core therapeutic areas: oncology, central nervous system, autoimmunity and anti-infection. Furthermore, we are also actively expanding our presence in disease areas with significant clinical needs in the future. Our industry-leading capabilities and commitment to synergistic innovation have also enabled various strategic collaborations and we are seen as the partner of choice by innovative biopharmaceutical companies, medical institutes, and research teams in China and globally.